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Abstract
Haemophilus ducreyi resists the cytotoxic effects of human antimicrobial peptides (APs), in-
cluding α-defensins, β-defensins, and the cathelicidin LL-37. Resistance to LL-37, mediated
by the sensitive to antimicrobial peptide (Sap) transporter, is required forH. ducreyi virulence
in humans. Cationic APs are attracted to the negatively charged bacterial cell surface. In
other gram-negative bacteria, modification of lipopolysaccharide or lipooligosaccharide
(LOS) by the addition of positively charged moieties, such as phosphoethanolamine (PEA),
confers AP resistance by means of electrostatic repulsion.H. ducreyi LOS has PEAmodifi-
cations at two sites, and we identified three genes (lptA, ptdA, and ptdB) inH. ducreyiwith
homology to a family of bacterial PEA transferases. We generated non-polar, unmarked mu-
tants with deletions in one, two, or all three putative PEA transferase genes. The triple mutant
was significantly more susceptible to both α- and β-defensins; complementation of all three
genes restored parental levels of AP resistance. Deletion of all three PEA transferase genes
also resulted in a significant increase in the negativity of the mutant cell surface. Mass spec-
trometric analysis revealed that LptA was required for PEAmodification of lipid A; PtdA and
PtdB did not affect PEAmodification of LOS. In human inoculation experiments, the triple
mutant was as virulent as its parent strain. While this is the first identified mechanism of resis-
tance to α-defensins inH. ducreyi, our in vivo data suggest that resistance to cathelicidin LL-
37 may be more important than defensin resistance toH. ducreyi pathogenesis.
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Introduction
Haemophilus ducreyi, the causative agent of the sexually transmitted disease chancroid, is a
gram-negative obligate human pathogen [1,2]. Chancroidal infection has been shown to facili-
tate the transmission and acquisition of HIV [3]. Recent studies have demonstrated that
H. ducreyi is also a prominent cause of non-sexually transmitted chronic cutaneous limb ulcer-
ations in the South Pacific [4–6]. During infection, H. ducreyi encounters host immune cells
and resident keratinocytes that secrete cationic antimicrobial peptides (APs), which target the
bacterial cell membrane and lyse the cell [7–10].H. ducreyi has been shown to resist the lethal
activity of several classes of human APs, including α-defensins, β-defensins, and the human
cathelicidin, LL-37 [11]. We previously identified two mechanisms of AP resistance in
H. ducreyi, including the sensitive to antimicrobial peptides (Sap) transporter and the multiple
transferable resistance (MTR) efflux pump. The Sap transporter confers resistance to LL-37 in
vitro and is required for virulence in humans [12,13]. The MTR efflux pump confers resistance
to LL-37 and to β-defensins in vitro [14]; its contribution toH. ducreyi pathogenesis in
vivo has not yet been studied. Neither the Sap nor MTR transporter confers resistance to
α-defensins [12–14].
One mechanism of AP resistance is to modify the cell surface with positively charged moie-
ties, which results in electrostatic repulsion of the positively charged APs [15]. Frequently,
gram-negative bacteria modify their lipopolysaccharide (LPS) or lipooligosaccharide (LOS)
with positively charged aminoarabinose or phosphoethanolamine (PEA) [16–23].H. ducreyi
does not modify its LOS with aminoarabinose; however, H. ducreyi LOS contains one PEA on
the lipid A and a second PEA on the KDO of its core oligosaccharide [24,25].
Modification of LPS or LOS with PEA has been shown to be advantageous for pathogenesis
in several bacteria. In the pathogenic Neisseria, three PEA transferases have been identified, in-
cluding LptA, Lpt-3 and Lpt-6, which modify the lipid A or the Heptose II core sugar at the
third or sixth position, respectively. In N. gonorrhoeae and N.meningitidis, these PEA
modifications contribute to resistance to polymyxin B, protegrin-1, and LL-37; resistance to
human serum was conferred by PEA transferases in N. gonorrhoeae but not N.meningitidis
[19,20,22,23]. PEA modification of lipid A in N. gonorrhoeae also contributes to survival in
both the murine female genital tract and the human male urethra [26,27]. In Salmonella enter-
ica and Escherichia coli, the PEA transferases CptA and EptB modify the Heptose II or KDO
core sugars of the LPS, respectively; lipid A is also modified with PEA by EptA in S. enterica or
PmrC in E. coli [18,28]. These PEA modifications of the LPS are important for resistance to
polymyxin B in these enteric organisms [17,18,21]. Additionally, competitive infection experi-
ments in mouse models of S. enterica infection showed a decrease in survival of PEA transfer-
ase mutants when compared to wild-type strains [17].
In addition to LPS and LOS, PEA transferases can modify other bacterial cell surface struc-
tures. Recently, studies have shown that the Campylobacter jejuni PEA transferase EptC modi-
fies both lipid A and the flagellum with PEA; these modifications contribute to resistance of
human and avian β-defensins and polymyxin B [29,30]. N. gonorrhoeaemodifies its Type IV
pili with PEA, although the function of this modification is unclear [31]. In addition to cell sur-
face structures, the recently described PEA transferase OpgE (also known as YbiP) modifies
osmoregulated periplasmic glucans (OPGs) in E. coli [32–34].
All characterized PEA transferases in gram-negative pathogens are members of the YhjW/
YjdB/YijP/YbiP family of enzymatic inner membrane proteins [19]. The H. ducreyi genome
encodes three genes that have strong homology to this family of PEA transferases (Table 1).
We predicted that these genes, lptA, ptdA, and ptdB, contribute to AP resistance and virulence
ofH. ducreyi. In this study, we generated deletion mutants lacking one, two, or three putative
PEA Transferases inH. ducreyi
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PEA transferase genes inH. ducreyi. Using these mutants, we examined the role that these pu-
tative PEA transferase genes play inH. ducreyi resistance to APs. We also analyzed the contri-
butions of these gene products to cell surface charge and LOS structure. Lastly, we utilized the
human model ofH. ducreyi infection to determine whether these PEA transferase genes are re-
quired for virulence in vivo.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids are listed in Table 2. Unless otherwise mentioned,H. ducreyi
strains were grown at 33°C with 5% CO2 on chocolate agar plates supplemented with 1% IsoVi-
talex. If strains contained plasmid vectors or antibiotic resistance cassettes, appropriate antibi-
otics were added to the agar, including spectinomycin (200 μg/ml), kanamycin (20 μg/ml) or
streptomycin (100 μg/ml) [12]. Liquid cultures of H. ducreyi were grown in Columbia broth
supplemented with hemin (50 μg/ml) (Aldrich Chemical Co., Milwaukee, WI), 5% heat inacti-
vated fetal bovine serum (HyClone, Logan, UT), and 1% IsoVitalex and, when applicable, with
half the concentration of appropriate antibiotics used in agar medium. For the human inocula-
tion experiments, the bacteria were grown in a proteose-peptone based broth, as described
[35]. E. coli strains were grown at 37°C in Luria-Bertani broth with appropriate antibiotics,
which include spectinomycin (50 μg/ml), ampicillin (50 μg/ml), kanamycin (50 μg/ml), or
streptomycin (100 μg/ml), with the exception of strain DY380, which was grown in L-Broth at
32°C or 42°C as indicated [36,37].
Deletion of ptdA, lptA, and ptdB in H. ducreyi
We used the recombineering technique, as described in [14], to generate unmarked, non-polar
mutants with deletions in lptA, ptdA, or ptdB, as well as mutants with deletions in two or three
of these genes (Table 2). This method allows for the deletion of the desired genes, leaving a
short open reading frame that includes the start codon of the deleted gene, 27 codons encoding
a FLP scar peptide, and the last 7 codons of the deleted gene [36]. Briefly, PCR products of
5.5 kb containing ptdA, 3.5 kb containing lptA, or 5.0 kb containing ptdB were generated
with HD0371for3 and HD0371rev3, HD0852for1 and HD0852rev1, or HD1598for3 and
HD1598rev3, respectively (Table 3). These products were cloned into E. coli, which was then
transformed with a 2.2 kb PCR fragment containing a spectinomycin resistance (SpecR) cas-
sette flanked by flippase (FLP) recognition target (FRT) sites and 50 bp of each respective
target gene, which was amplified by H1P1HD0371 and H2P2HD0371, H1P1HD0852 and
H2P2HD0852, or H1P1HD1598 and H2P2HD1598 (Table 3). After recombination, each frag-
ment was ligated into pRSM2072 to generate the mutagenic plasmid pMEB252 (for ptdA),
pMEB256 (for lptA), or pMEB251 (for ptdB).
Table 1. PutativeH. ducreyi PEA transferases.
H. ducreyi Gene ID H. ducreyi Protein Homologous Protein (organism) Expect Value Site of Action
HD0852 Lipid A PEA transferase LptA LptA (N. gonorrhoeae) 0 lipid A
LptA (N. meningitidis) 0 lipid A
EptA/PmrC (E. coli) 3e-138 lipid A
EptA/PmrC (S. enterica) 2e-134 lipid A
HD0371 PEA transferase of H. ducreyi PtdA OpgE/YbiP (E. coli) 1e-76 unknown
HD1598 PEA transferase of H. ducreyi PtdB OpgE/YbiP (E. coli) 1e-62 unknown
doi:10.1371/journal.pone.0124373.t001
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Table 2. Bacterial strains and plasmids used in study.
Strain or Plasmid Genotype or Description Source
Strains
35000HP Human-passaged variant of Class I clinical isolate 35000 [38]
35000HP/pLSSK 35000HP with vector pLSSK; StrepRa [14]
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araΔ139 Δ(ara-leu)7697 galU galK rpsL (StrRR)
endA1 nupGλ-
Invitrogen
E. coli DY380 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZ M15 ΔlacX74 deoR recA1 endA1 araD139 Δ(ara, leu) 7649 galU galK
rspL nupG (λcI857 (cro-bioA) <> tet)
[37]
35000HPΔptdA Unmarked ptdA deletion mutant of 35000HP This
study
35000HPΔlptA Unmarked lptA deletion mutant of 35000HP This
study
35000HPΔptdB Unmarked ptdB deletion mutant of 35000HP This
study
35000HPΔptdA lptA Unmarked ptdA lptA deletion mutant of 35000HP This
study
35000HPΔlptA ptdB Unmarked lptA ptdB deletion mutant of 35000HP This
study
35000HPΔptdA ptdB Unmarked ptdA ptdB deletion mutant of 35000HP This
study








35000HPΔPEAT with complement vector pPEAT; StrepR This
study
FX517 dsrA:cat insertion mutant of 35000; CmR [39]
Plasmids
pLSSK H. ducreyi shuttle vector; StrepR [40]
pPEAT ptdA lptA ptdB in pLSSK; StrepR This
study
pRSM2072 Suicide vector; AmpR [41]
pRSM2975 FLP recombinase vector [36]
pMEB252 ptdA replaced with SpecR cassette in pRSM2072 This
study
pMEB256 lptA replaced with SpecR cassette in pRSM2072 This
study
pMEB251 ptdB replaced with SpecR cassette in pRSM2072 This
study
pCR-XL-TOPO TA cloning vector; KanR Invitrogen
pMEB346 ptdA in pCR-XL-TOPO; KanR This
study
pMEB344 lptA in pCR-XL-TOPO; KanR This
study
pMEB348 ptdB in pCR-XL-TOPO; KanR This
study
pMEB355 ptdA in pLSSK; StrepR This
study
pMEB356 lptA ptdB in pCR-XL-TOPO; KanR This
study
a StrepR, resistance to streptomycin; CmR, resistance to chloramphenicol; AmpR, resistance to ampicillin; KanR, resistance to kanamycin; SpecR,
resistance to spectinomycin.
doi:10.1371/journal.pone.0124373.t002
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Each mutagenic plasmid was individually transformed into H. ducreyi as previously de-
scribed [14], and mutant colonies were selected and transformed with pRSM2975, a tempera-
ture sensitive plasmid containing FLP recombinase. Incubation with anhydrous tetracycline
induced the FLP recombinase, and after selection for loss of SpecR and loss of pRSM2975, the
resulting recombined strain is an unmarked, non-polar deletion mutant lacking the target
gene. This process was repeated with each mutagenic plasmid to create a strain collection lack-
ing any combination of one, two, or three of the putative PEA transferase genes ptdA, lptA, and
ptdB (Table 2). In all mutants, PCR and sequence analyses confirmed loss of target gene(s). For
the mutant lacking all three genes, designated 35000HPΔPEAT (“PEAT” stands for “PEA
Transferases”), whole genome sequencing revealed identical DNA between the mutant and
parent strain 35000HP, with the exception of the loss of the three target genes. Growth curves
indicated no significant changes in the growth rate of 35000HPΔPEAT compared to 35000HP,
and outer membrane profiles showed no change in 35000HPΔPEAT when compared to
35000HP (data not shown). By silver-stained gel, the LOS banding pattern was identical be-
tween 35000HP and 35000HPΔPEAT (data not shown), which was expected, given the 123 Da
molecular mass of PEA.
Complementation of ptdA, lptA, and ptdB in trans
To complement the mutations in 35000HPΔPEAT, fragments of 2.05 kb, 2.5 kb, and 1.95 kb,
containing 164 bp, 340 bp, and 185 bp 5’ of the ptdA, lptA, and ptdB ATG start sites, respective-
ly, including the predicted promoter regions, were amplified from genomic DNA of 35000HP
Table 3. Primers used in this study.
Primer Construct or use Sequence
HD0371for3 ptdA fragment ACTAGTGGCTCACCAAGCCATTGGTTACAA
HD0371rev3 ptdA fragment ACTAGTGCAGGAATTGTACGGTCTGAACG
HD0852for1 lptA fragment ACTAGTAGGGAAATGATCCGAAGCGAGGA
HD0852rev1 lptA fragment ACTAGTTCGGTCGTATTAACGTGCTGACCA
HD1598for3 ptdB fragment ACTAGTTGGCAAATTAAACCACACGCGGTC













HD0852for3 internal lptA probe TTGTTTGTTCTCGTCGCAAACCCG
HD0852rev3 internal lptA probe AGTAAGTTGGTCCATGGCTACCGA
HD0371for2 internal ptdA probe ATCAGGAGAAGCAGGAGTTACTGG
HD0371rev2 internal ptdA probe GTTGCCGGCGCACTAGCAATATAA
HD1598for2 internal ptdB probe TGACGTTCTTGGTCGTCACTCGAA
HD1598rev2 internal ptdB probe CCCGCCAAATACCACGATATCAAC
doi:10.1371/journal.pone.0124373.t003
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with primers HD0371compfor1 and HD0371comprev3, HD0852compfor1 and HD0852com-
prev1, and HD1598compfor1 and HD1598comprev1. These fragments were TA-cloned into
pCR-XL-TOPO (Invitrogen, Carlsbad, CA), resulting in pMEB346 (containing ptdA),
pMEB344 (containing lptA), and pMEB348 (containing ptdB).
The 2.05 kb ptdA fragment was excised from pMEB346 by digestion with NotI and SpeI and
ligated into the shuttle vector pLSSK, resulting in the 5.6 kb plasmid pMEB355. The 2.5 kb lptA
fragment of pMEB344 was excised by digestion with SpeI and XbaI and ligated into SpeI-
digested, shrimp alkaline phosphatase-treated pMEB348 to form an 8.0 kb plasmid, pMEB356,
which contained lptA followed by ptdB in the same orientation. The 4.5 kb lptA ptdB fragment
was then excised from pMEB356 by digestion with SpeI and ApaI and ligated into pMEB355.
The resulting plasmid, pPEAT, contains a 10.1 kb fragment containing ptdA, lptA, and ptdB, in
the same orientation and along with their native promoter regions, in pLSSK. 35000HPΔPEAT
was transformed with pPEAT to obtain 35000HPΔPEAT/pPEAT. Expression of lptA, ptdA,
and ptdB in 35000HPΔPEAT/pPEAT was confirmed by qRT-PCR, as previously described
[12], and the expression level of each PEA transferase gene was within ± 2-fold of parental ex-
pression levels (data not shown). To achieve isogenicity with the complemented mutant strain,
all assays in which the parent, mutant, and complemented mutant strains were compared uti-
lized pLSSK-bearing derivatives of the parent and mutant strains (35000HP/pLSSK and
35000HPΔPEAT/pLSSK, respectively).
Antimicrobial peptide bactericidal assays
Recombinant α- and β-defensin peptides were purchased from PeproTech Inc. (Rocky Hill,
NJ: HNP-1, HBD-2, HBD-3), Peptides International (Louisville, KY: HD-5), and Sigma-
Aldrich (St. Louis, MO: HNP-2); synthetic LL-37 was purchased from Phoenix Pharmaceuti-
cals, Inc. (Belmont, CA). APs were reconstituted as previously described [14].
AP assays were performed as described previously [11]. Briefly, approximately 1000 CFU of
mid-logarithmic phaseH. ducreyi were incubated with 0.2, 2.0, and 20 μg/mL of diluted pep-
tide for one hour. Samples were plated in triplicate on chocolate agar plates supplemented with
appropriate antibiotics, and survival at each concentration of peptide after one hour was com-
pared to survival of a control sample receiving diluent but no peptide. We used a Student’s
t-test with Sidak adjustment for multiple comparisons to determine statistical significance, and
comparisons between strains for sensitivity to a given AP were made only when assayed side-
by-side.
Serum bactericidal assay
35000HP/ pLSSK, 35000HPΔPEAT/pLSSK, and 35000HPΔPEAT /pPEAT were assayed for
survival in human serum, as described previously [39]. Briefly, 14–16 hour growth from con-
fluent plates was scraped into GC broth and diluted to 1000 CFU/ml. Bacteria were mixed 1:1
with either active or heat-inactivated human serum. Survival was determined by plate count
after 45 min incubation. Assays were performed in triplicate, and the percent survival was cal-
culated as the ratio of the (average active serum CFU/plate) / (average heat-inactivated serum
CFU/plate) for each strain. The serum-sensitive, dsrA-deficient mutant strain FX517 was in-
cluded in the assay as an internal control [39]; we used a Student’s t test with Sidak adjustment
for multiple comparisons to determine statistical significance.
Cell surface charge assay
We compared the cell surface charges of 35000HP, 35000HPΔPEAT, and 35000HPΔPEAT
/pPEAT by adapting protocols which used the cationic dye Alcian Blue to compare membrane
PEA Transferases inH. ducreyi
PLOSONE | DOI:10.1371/journal.pone.0124373 April 22, 2015 6 / 20
charge changes in red blood cells and yeast [42,43].H. ducreyi strains were grown to mid-
logarithmic phase, harvested, washed, and diluted in sterile phosphate buffered saline (PBS).
Approximately 1000 CFU of bacteria were incubated for 30 minutes with 100 μg/mL Alcian
Blue 8GX (Sigma-Aldrich, St. Louis, MO) in PBS; control samples were incubated in PBS
alone. The bacteria were centrifuged and the supernatant removed, and the pellet was then sus-
pended in 500 μL PBS. Absorbance at OD607nm was measured for both the supernatant and
suspended bacteria. Parallel bacterial samples were used to determine dry weight, and the ab-
sorbance measurements were normalized to the parent strain. Strains were compared for the
amount of dye bound to the bacteria (by both loss of dye in supernatant and gain of dye in bac-
terial cells), normalized to the dry weight of each bacterial cell sample, using the PBS control
samples to account for background absorption levels. A comparative decrease in remaining
dye in the supernatant sample and a comparable increase in dye bound to the bacterial cells
correlates with the bacterial cell having a more negative outer membrane charge.
For statistical analysis, mutant-parent pair differences in absorbance readings from both
bacteria and supernatants from each strain were computed to account for day-to-day sample
variation. Since the absorbance measurements were not normally distributed, non-parametric
Wilcoxon signed rank tests were used to test for significant differences between mutant and
parent samples.
MALDI-MS analysis of H. ducreyi LOS
LOS was extracted from H. ducreyi using a microphenol method, as previously described [44].
Briefly, plate-grown bacteria were harvested, washed with PBS, and then diluted in H2O. The
aqueous phase of a 65°C phenol/water extraction was kept, and the LOS was precipitated over-
night at -20°C with cold ethanol and then lyophilized overnight. For each strain examined,
LOS samples were prepared in triplicate.
To generate LOS amendable for mass spectrometric analyses, O-deacylated LOS (O-LOS)
samples were prepared by treating 50–100 μg of LOS with 50 μl of anhydrous hydrazine fol-
lowed by acetone precipitation as described previously [45]. All samples were desalted by drop
dialysis using 0.025-μm pore size nitrocellulose membranes (Millipore, Bedford, MA) and were
subsequently lyophilized. Samples were reconstituted in high-performance liquid chromatog-
raphy (HPLC) grade H2O; 1 μl was loaded onto the target, allowed to dry, and then overlaid
with either 1 μl of matrix (50 mg/ml 2,5-dihydroxybenzoic acid (DHB) (Laser Biolabs, Sophia-
Antipolis Cedex, France) in 70% acetonitrile) or DHB made as a saturated solution in 70% ace-
tonitrile. Samples were subsequently analyzed using matrix-assisted laser desorption ionization
mass spectrometry (MALDI-MS) on an LTQ linear ion trap mass spectrometer coupled to a
vMALDI ion source (MALDI-LIT) (Thermo Fisher, Waltham, MA). The vMALDI source uses
a nitrogen laser that operates at 337.1-nm wavelength, 3-ns pulse duration, and 60-Hz repeti-
tion rate. Data were collected in the negative ion mode using the automated gain control and
the automatic spectrum filter settings. Alternatively, samples were analyzed on the Waters
Synapt G2 hybrid mass spectrometer utilizing the MALDI ionization source in the negative
ion mode.
Human model of H. ducreyi infection
Human subjects research was performed in accordance with the human experimentation
guidelines of the U.S. Department of Health and Human Services and the Institutional Review
Board of Indiana University–Purdue University Indianapolis under study #93–1237. This
study was reviewed and approved by the Institutional Review Board of Indiana University-
Purdue University-Indianapolis prior to initiation of the experiments involving human
PEA Transferases inH. ducreyi
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subjects. Prior to participation, written informed consent was obtained from each human sub-
ject for study participation and for HIV serology.
For the human model of H. ducreyi infection, we used the strains 35000HP and
35000HPΔPEAT. Three healthy male and five healthy female volunteers over 21 years of
age were recruited for the study.
The experimental human challenge protocols were followed as previously described
[35,38,46–49]. Subjects were inoculated on the upper arm; one arm was inoculated at 3 sites
with a targeted dose of 90 CFU of the parent strain, and the other arm was inoculated at 3 sites
with targeted doses of 45, 90, and 180 CFU of the mutant strain (see Results section for the ac-
tual inoculum doses achieved). Subjects were observed until they reached the clinical endpoint,
defined as either 14 days post-inoculation, resolution of infection at all sites, or development of
a pustule that was painful or pruritic or at least 6 mm in diameter. The clinician following the
participants were blinded to the identity of the arm that had been inoculated with the mutant
or parent strains. Following the clinical endpoint, the code was broken, and biopsies were
taken of both a parent site and mutant site. The subjects were then treated with a single dose of
oral ciprofloxacin. Papule and pustule formation rates for parent and mutant inoculation sites
were compared using logistic regression with generalized estimating equations (GEE) to ac-
count for the within-subject correlation. Ninety-five percent confidence intervals (95% CI) for
papule and pustule formation rates were calculated using GEE-based sandwich standard errors.
Day 1 papule size was compared using analysis of variance with a random subject effect.
To confirm that the inocula contained the correct strains and that there was no cross con-
tamination of the inoculated sites, DNA hybridization was performed on colonies derived
from the inocula and from surface cultures and biopsies of infected sites. Probes specific for
dnaE, lptA, ptdA, and ptdB were amplified using primers reported previously [36], and
HD0852for3/HD0852rev3, HD0371for2/HD0371rev2, and HD1598for2/HD1598rev2, respec-
tively (Table 3). The probes were labeled with digoxigenin using the DIG DNA labeling kit and
detected using the DIG Easy Hyb protocol (Roche Applied Sciences) as described [36].
Results
Identification of putative PEA transferases in H. ducreyi
Previously, we established that the Sap transporter and MTR efflux pump mediated LL-37 and
β-defensin resistance inH. ducreyi [12–14]. We wanted to identify a mechanism responsible
for α-defensin resistance. Similar to other bacteria, H. ducreyi LOS is modified with the
positively charged PEA, leading to our hypothesis thatH. ducreyi PEA modification confers re-
sistance to APs. Homology searches found three members of the YhjW/YjdB/YijP/YbiP family
in the H. ducreyi genome (Table 1).HD0852 (lptA) shared strong homology with lipid A PEA
transferase genes in Neisseria, E. coli, and S. enterica. HD0371 (ptdA) andHD1598 (ptdB) were
homologous to the OPG-modifying PEA transferase OpgE in E. coli.
The H. ducreyi PEA transferase genes confer resistance to α- and
β-defensins but not to cathelicidin or human serum
In order to determine the contribution of each putative PEA transferase gene to AP resistance,
mutants were made with deletions in one, two, or all three genes (Table 2). This panel of
mutants was used to assess the role of these genes in resistance to human APs relevant to
H. ducreyi infection, including APs secreted by resident keratinocytes (β-defensins, LL-37 and,
in vaginal epithelial cells, α-defensin HD-5) or infiltrating neutrophils (α-defensins, HBD-4,
PEA Transferases inH. ducreyi
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and LL-37) and macrophages (β-defensins and LL-37) [7–9]. Initial assays used HD-5 and
HBD-3 as representative α- and β-defensins, respectively, and the cathelicidin LL-37.
We found that loss of any one PEA transferase gene had no significant effect on AP resis-
tance (data not shown). When two PEA transferase genes were deleted, all double mutant com-
binations were significantly more susceptible than 35000HP to the β-defensin HBD-3 at
multiple concentrations (Fig 1). These mutants with deletions in two PEA transferase genes
showed no increase in sensitivity to HD-5 or LL-37 (data not shown).
To determine the collective contribution of all three PEA transferase genes to AP resistance,
we assayed 35000HP/pLSSK, 35000HPΔPEAT/pLSSK, and 35000HPΔPEAT/pPEAT for
sensitivity to α-defensins, β-defensins, and LL-37 at various concentrations. We found that
35000HPΔPEAT was significantly more sensitive to the α-defensin HD-5 at all concentrations
tested; complementation with pPEAT restored the parental resistance phenotype (Fig 2A).
Similar results were obtained when the parent, mutant, and complemented mutant were chal-
lenged with the additional human α-defensins HNP-1 and HNP-2 (S1 Fig). These data indicate
that the lptA, ptdA, and ptdB gene products contribute to α-defensin resistance inH. ducreyi.
Next, we found that 35000HPΔPEAT was significantly more susceptible to the β-defensin
HBD-3 at 2 concentrations, and complementation with pPEAT restored the parental resistance
phenotype (Fig 2B). Similar results were obtained when the parent, mutant, and complemented
mutant were challenged with the human β-defensin HBD-2 (S1 Fig). These data indicate that
the lptA, ptdA, and ptdB gene products contribute to β-defensin resistance inH. ducreyi.
We found no significant difference in sensitivity to LL-37 between 35000HP and
35000HPΔPEAT at any concentration (Fig 2C). Taken together, these data suggest that the
Fig 1. Deletion of two putative PEA transferase genes inH. ducreyi increases susceptibility to HBD-3.
(A) 35000HPΔlptA ptdA, (B) 35000HPΔlptA ptdB, and (C) 35000HPΔptdA ptdBwere compared with
35000HP for resistance to the β-defensin HBD-3. All three mutants lacking two putative PEA transferase
genes were significantly more sensitive than 35000HP to HBD-3, indicated by asterisks (P < 0.05). Data
represent average ± standard error of 3–4 independent assays, and statistical significance was determined
by Student’s t-test.
doi:10.1371/journal.pone.0124373.g001
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H. ducreyi PEA transferase gene products likely contribute to α- and β-defensin resistance but
do not contribute significantly to cathelicidin resistance.
Addition of PEA to LOS contributes to serum resistance in N. gonorrhoeae [22]. In contrast,
we found no significant difference in sensitivity to normal human serum between 35000HP
and 35000HPΔPEAT (Fig 3). These data indicate that the putative PEA transferases of
H. ducreyi likely do not contribute to resistance to human serum.
35000HPΔPEAT had a more negative cell surface charge than
35000HP
Once we established that the PEA transferase genes contributed to defensin resistance, we next
examined whether these transferase genes affected the cell surface charge ofH. ducreyi. To
compare the relative cell surface charges of 35000HP and 35000HPΔPEAT, we modified a pro-
tocol that uses the cationic dye Alcian Blue 8GX, which proportionately binds to the cell sur-
face based on charge.
When comparing 35000HPΔPEAT to 35000HP (Table 4), we found 17.5% more dye bound
to 35000HPΔPEAT cells than to 35000HP cells (P< 0.0001). We also found 16.5% less dye re-
maining in the supernatant from 35000HPΔPEAT cells than from 35000HP cells (P< 0.0001).
Complementation with the three PEA transferase genes restored the level of dye bound to that
of 35000HP (data not shown). These data indicated that the cell surface of 35000HPΔPEAT
was more negatively charged than 35000HP, suggesting that the putative PEA transferase gene
products conferred the addition of positive moieties on the cell surface.
Fig 2. H. ducreyi PEA transferases confer resistance to α- and β-defensins. 35000HP, 35000HPΔPEAT
and 35000HPΔPEAT/pPEAT were tested for resistance to the (A) α-defensin HD-5 (B) β-defensin HBD-3,
and (C) human cathelicidin LL-37. Asterisks indicate statistically significant differences from 35000HP
(P < 0.05). Complementation with pPEAT restored parental levels of susceptibility to defensins. Data
represent average ± standard error of six independent replicates, and statistical significance was determined
by Student’s t-test.
doi:10.1371/journal.pone.0124373.g002
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H. ducreyi LptA modifies lipid A with phosphoethanolamine.
After determining that the PEA transferase genes played a role in modifying theH. ducreyi cell
surface charge, we hypothesized that the observed surface charge effects would correlate with
PEAmodification ofH. ducreyi LOS. We tested this hypothesis by analyzing the LOS structures
of each single mutant as well as the parent, triple mutant, and complemented triple mutant via
mass spectrometry.
LOS samples from each strain were O-deacylated to generate water soluble O-LOS that was
analyzed by MALDI-MS. Lipid A and oligosaccharide (OS) “prompt fragments” are generated
within the instrument during the ionization process. These fragments can provide useful infor-
mation in determining LOS structures, as they allow one to observe the masses of these individ-
ual components of the O-LOS in the same analyses as the intact O-LOS structures.
To define the full contribution of the putative PEA transferases to LOS structure, triplicate
O-LOS samples from 35000HP/pLSSK, 35000HPΔPEAT/pLSSK, and 35000HPΔPEAT/
Fig 3. H. ducreyi PEA transferases do not confer resistance to human serum. 35000HP,
35000HPΔPEAT and FX517 were examined for resistance to human serum. There was no significant
difference in sensitivity to serum between 35000HP and 35000HPΔPEAT; FX517, a ΔdsrAmutant that
served as a control for serum sensitivity, was significantly more sensitive to serum than 35000HP, indicated
by asterisk (P < 0.05). Data represent average ± standard error of six independent assays, and statistical
significance was determined by Student’s t-test.
doi:10.1371/journal.pone.0124373.g003
Table 4. Cell surface of 35000HPΔPEAT is more negatively charged than 35000HP.
Sample Strain Mean S.D.b Median Wilcoxon p-valuea
Bacterial Cells 35000HP 0.280 0.203 0.217 <0.0001
35000HPΔPEAT 0.329 0.237 0.268
Supernatant 35000HP 0.588 0.602 0.374 <0.0001
35000HPΔPEAT 0.491 0.532 0.313
a Statistical signiﬁcance determined by comparing median values with a non-parametric Wilcoxon signed ranks test because the absorbance
measurements were not normally distributed; experimental n = 24
b S.D., Standard deviation
doi:10.1371/journal.pone.0124373.t004
PEA Transferases inH. ducreyi
PLOSONE | DOI:10.1371/journal.pone.0124373 April 22, 2015 11 / 20
pPEAT were prepared and analyzed by MALDI-MS. Fig 4 and Table 5 show representative
data from these analyses. The O-deacylated monophosphorylated lipid A (MPLA) atm/z 951.6
or 951.4 was observed in 35000HP/pLSSK as well as in 35000HPΔPEAT and its corresponding
complemented strain. The peak atm/z 1074.5, which corresponds to a MPLA with the addition
of one PEA (+ 123 Da), was observed in the parent strain and the complemented mutant strain,
but was not observed in 35000HPΔPEAT. Thus, 35000HPΔPEAT lacked the wild-type PEA
modification of its lipid A.
Full O-LOS glycoforms, which contain O-deacylated lipid A, the core, and varying lengths
of the branch oligosaccharide, are shown in Table 5 for each strain. Evaluation of these O-LOS
glycoforms showed that all three strains had PEA present on the oligosaccharide. Glycoforms
Fig 4. H. ducreyi putative PEA transferases contribute to modification of lipid A with PEA. Negative-ion
MALDI-MS spectra ofO-LOS from (A) 35000HP/pLSSK, (B) 35000HPΔPEAT/pLSSK, and (C)
35000HPΔPEAT/pPEAT. The compositions of the glycoforms are described in Table 5. Masses labeled in
bold were only observed in the parent strain and the corresponding PEAT complemented strain. The asterisk
in the glycoform nomenclature designates the number of PEA groups present on theO-LOS.
doi:10.1371/journal.pone.0124373.g004
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containing one PEA were observed in all three strains atm/z 3123, 2832, 2670, 2467, and 2304
(Table 5). Glycoforms containing two PEA groups were observed in both the parent strain and
the complemented mutant strain atm/z 3268 and 2977 (Table 5); these data are consistent
with previous work showing that H. ducreyi LOS contains one PEA on its lipid A and one PEA
on its core oligosaccharide. In contrast, the masses corresponding to O-LOS structures with
two PEA groups were not observed in 35000HPΔPEAT (Table 5). The lack of PEA on the lipid
A from 35000HPΔPEAT, combined with the presence of one PEA on the oligosaccharide of
the O-LOS from this strain, demonstrated that, in this mutant, the lipid A PEA transferase was
inactive but a second PEA transferase, responsible for the addition of PEA onto the oligosac-
charide, was still active.
The lipid A prompt fragments provided the most useful information for the analyses of the
O-LOS from the single mutants strains. Representative spectra of the lipid A regions of the
O-LOS from the single mutant strains and the corresponding parent strain are shown in Fig 5.
The peak atm/z 951.5, corresponding to the MPLA, was observed in all three single mutants
(35000HPΔptdA, 35000HPΔptdB, and 35000HPΔlptA) as well as the parent strain. The MPLA
with the addition of one PEA, found atm/z 1074.5, was observed in the parent strain as well as
the 35000HPΔptdA and 35000HPΔptdB strains, but was not observed in the 35000HPΔlptA
strain. These data indicate that LptA confers the PEA modification to lipid A.
The H. ducreyi lptA, ptdA, and ptdB genes are not required for survival
in vivo
We next examined the role of the PEA transferase genes in virulence in vivo by using the
human model ofH. ducreyi infection. To do this, we challenged eight healthy adult volunteers
with 58–139 CFU of 35000HP and 40–224 CFU of 35000HPΔPEAT (Table 6).
Of sites inoculated with 35000HP, 23 of 24 (95.8%) developed papules, while 21 of 24
(87.5%) sites inoculated with 35000HPΔPEAT developed papules. The average parent papule
size at day 1 was 8.7 mm2 whereas the average mutant papule size at day 1 was 5.0 mm2.
Table 5. H. ducreyi O-LOS glycoforms and correspondingmonoisotopic masses.
[M-H]-obs
Glycoforma Hex HexNAc PEA NeuAc [M-H]-calc 35000HP/ pLSSK 35000HP ΔPEAT/ pLSSK 35000HP ΔPEAT/ pPEAT
bA5a1** 3 1 2 1 3268.07 3268.18
cnd 3267.82
A5a1* 3 1 1 1 3123.08 3123.00 3122.73 3122.73
A5a1 3 1 0 1 3000.07 2999.91 2999.73 2999.55
bA5** 3 1 2 0 2976.98 2977.09 nd 2976.73
A5* 3 1 1 0 2831.98 2831.91 2831.73 2831.64
A5 3 1 0 0 2708.98 2708.82 2708.64 2708.55
A4* 2 1 1 0 2669.93 2669.82 2669.64 2669.55
A4 2 1 0 0 2546.92 2546.73 2546.64 2546.55
A3* 2 0 1 0 2466.85 2466.64 2466.64 2466.45
A3 2 0 0 0 2343.84 2343.64 2343.55 2343.45
A2* 1 0 1 0 2304.80 2304.55 2304.55 2304.36
a All molecular masses contain four Heptoses, Kdo(P), and O-deacylated lipid A. Asterisks indicate the number of PEA present in the structure.
bGlycoforms were observed in their sodiated forms.
cnd indicates that the particular glycoform was not detected in the sample.
doi:10.1371/journal.pone.0124373.t005
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Pustules developed at 5/24 (20.8%) locations for both the 35000HP and 35000HPΔPEAT
inoculated sites.
Statistical comparisons between 35000HP and 35000HPΔPEAT showed no difference be-
tween their papule formation rates (parent = 95.8% [95% C.I., 88.2–99.9%], mutant = 87.5%
[95% C.I., 76.3–98.7%], P = 0.103) and their pustule formation rates (parent = 20.8% [95% C.I.,
Fig 5. LptA contributes to modification of lipid A with PEA. Negative-ion MALDI-MS spectra ofO-LOS
from (A) 35000HPΔptdB, (B) 35000HPΔptdA, (C) 35000HPΔlptA, and (D) 35000HP. The Fig shows zoomed
images from representative spectra for each strain. TheO-deacylated monophosphorylated lipid A (MPLA)
was observed atm/z 951.46 or 951.45, this structure plus the addition of PEA was observed atm/z 1074.46
or 1074.47. The MPLA plus PEA was not observed in the 35000HPΔlptA samples.
doi:10.1371/journal.pone.0124373.g005
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9.7–32.0%], mutant = 20.8% [95% C.I., 4.8–36.9%], P = 1.0). The difference in day 1 papule
size (parent 8.7 mm2, mutant 5.0 mm2) did approach statistical significance (P = 0.051).
Taken together, these data suggest that 35000HPΔPEAT does not contribute significantly to
H. ducreyi virulence during experimental human infection.
For each volunteer that developed pustules at both parent and mutant-inoculated sites, one
parent site and one mutant site were biopsied, stained with hematoxylin-eosin and anti-CD3
antibodies, and semi-quantitatively cultured as described [47]. All samples contained pustules
that eroded through the epidermis and a dense dermal infiltrate that predominantly consisted
of T cells (data not shown); mutant and parent sites were histopathologically indistinguishable.
All colonies recovered from the inocula, surface cultures and biopsies were tested for the
presence of dnaE, lptA, ptdA, and ptdB sequences by colony hybridization. The dnaE probe hy-
bridized to all the colonies tested from both parent (N = 141) and mutant (N = 142) inocula,
while the lptA, ptdA, and ptdB probes only hybridized to colonies from the parent inocula. At
least one positive surface culture for H. ducreyi was obtained during follow-up visits from 8%
of the parent sites and 8% of the mutant sites. The dnaE probe hybridized to colonies from
both parent (N = 94) and mutant (N = 70) inoculated sites, while the lptA, ptdA, and ptdB
probes only bound to colonies from the parent sites. All 4 paired biopsies of mutant and parent
pustules yielded H. ducreyi. The dnaE probe hybridized to all of both parent (n = 103) and mu-
tant (n = 107) colonies obtained from the biopsies, while the lptA, ptdA, and ptdB probes only
hybridized to colonies obtained from the parent biopsies. Thus, all colonies derived from the
inocula and the infected sites had the expected genotypes.
Table 6. 35000HPΔPEAT is fully virulent in vivo.
Response to inoculation of live H. ducreyi strains
Volunteera Genderb Observation period (days) Isolatec Dose (CFU) No. of initial papules No. of pustules at endpoint
441 M 7 P 58 3 1
M 56–224d 2 2
442 M 7 P 58 3 1
M 56–224d 3 1
444 F 9 P 70 3 0
M 40–159e 3 1
445 F 7 P 70 3 1
M 40–159e 2 0
446 F 7 P 70 3 1
M 40–159e 3 0
447 M 8 P 139 3 0
M 112 3 0
451 F 7 P 108 3 0
M 88 3 0
453 F 12 P 108 2 1
M 88 2 1
a Volunteers 441 and 442 were inoculated in the ﬁrst iteration. Volunteers 444, 445, and 446 were inoculated in the second iteration. Volunteer 447 was
inoculated in the third iteration. Volunteers 451 and 453 were inoculated in the fourth iteration.
b M, Male; F, Female
c P, 35000HP (parent); M, 35000HPΔPEAT (mutant)
d Mutant-inoculated sites received estimated delivered doses of 56, 112, or 224 CFU.
e Mutant-inoculated sites received estimated delivered doses of 40, 80, or 159 CFU.
doi:10.1371/journal.pone.0124373.t006
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Discussion
In gram-negative bacteria, PEA transferases modify a variety of substrates, including carbohy-
drate components of LPS, other sugars in the cell wall, and proteinaceous surface structures;
the best characterized PEA transferases are those that modify the LPS of enteric pathogens or
the LOS of N. gonorrhoeae. PEA modification contributes to AP resistance and serum resis-
tance in vitro and to virulence in vivo. InH. ducreyi, both lipid A and core components of the
LOS are modified with PEA. In this study, we examined threeH. ducreyi genes with strong ho-
mology to known PEA transferases.
We examined the effect of PEA modification on resistance to human APs relevant to
H. ducreyi infection, including α-defensins, β-defensins, and the cathelicidin LL-37. PEA modi-
fication did not appear to confer resistance to LL-37 (Fig 2C); however, previous studies have
already established that both Sap and MTR play major roles in LL-37 resistance [12–14]. The
presence of an intact Sap transporter and a functioning MTR efflux pump could mask any con-
tribution of PEA modification to LL-37 resistance. Clearly, however, PEA modification plays a
role inH. ducreyi resistance to α- and β-defensins. When any one putative PEA transferase
gene was deleted, we observed no difference in AP susceptibility between the parent and mu-
tant strains; however, when two of these genes were deleted, the mutants became more suscep-
tible to β-defensins (Fig 1). When all three putative PEA transferase genes were deleted, the
mutant became more susceptible than the parent strain to α-defensins. Thus, all three putative
PEA transferases contribute to defensin resistance.
When all three putative PEA transferases were deleted, we also observed a significant change
in surface charge of the organism (Table 4). Loss of only one putative PEA transferase gene
had no effect on surface charge in our assay (S2 Fig), which may reflect a lack of sensitivity
of the cationic dye assay. We also detected an increase in negativity in the cell surface in
35000HPΔptdA ptdB (S2 Fig), which correlates with its increased sensitivity to β-defensins;
these data indicate that PtdA and PtdB affect cell surface charge independent of LptA. Howev-
er, the greatest effect on surface charge was observed in the triple mutant and correlated with
its increased sensitivity to both α- and β-defensins. Thus, the additive effects of these three
gene products are what provides sufficient cell surface positivity to repel cationic APs.
In contrast to observations in N. gonorrhoeae, loss of the three putative PEA transferase
genes did not affect the susceptibility of H. ducreyi to human serum [22]. Our results indicate
that in H. ducreyi, as in N.meningitidis [17], PEA modification likely does not contribute to
complement evasion. H. ducreyi expresses three surface proteins, the ducreyi serum resistance
protein DsrA, the ducreyi lectin DltA, and the major outer membrane protein MOMP, that
have been previously shown to confer resistance to complement-mediated killing [39,50,51].
DsrA blocks binding of IgM to theH. ducreyi surface and prevents initiation of the comple-
ment cascade, whereas the contributions of DltA and MOMP to serum resistance remain un-
clear [39,50]. Thus, in H. ducreyi, the activities of DsrA and other outer membrane proteins
may be masking any contribution of PEA modification on serum resistance.
As discussed above, our data suggest that all three putative PEA transferase genes in
H. ducreyi contribute to lessening the negativity of the cell surface (Table 4). Mass spectrometric
analysis indicated that LptA functions by modifying lipid A with PEA (Figs 4–5); the functions
of PtdA and PtdB are less clear. Loss of either gene product had no effect on the modification of
lipid A (Fig 5), but both gene products contributed to AP resistance (Figs 1–2). These genes also
contributed to effects on cell surface charge even in the absence of LptA (S2 Fig). The closest ho-
molog of these genes, opgE, encodes a PEA transferase that targets OPGs. OPGs and related
periplasmic glucans have been found in disparate gram-negative bacteria [32]. However, no
OPG-like molecules and no OPG biosynthetic genes, except for opgE, have been found among
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the Pasteurellaceae, which includesH. ducreyi. Thus, OpgE homologs in the Pasteurellaceae,
such as PtdA and PtdB, likely target other molecules; our data suggest that PtdA and PtdB affect
other surface structures. There is precedence for PEA transferases to modify surface proteins.
C. jejunimodifies its flagellum with PEA, andN. gonorrhoeaemodifies its type IV pilus with
PEA [29,31].H. ducreyi does not produce these surface structures; we are currently investigating
the role that PtdA and PtdB play in modification of surface components other than LOS.
The other question raised by the mass spectrometric analyses is what gene product is re-
sponsible for modifying theH. ducreyi KDO with PEA? The PEA modification of KDO was de-
tected by mass spectrometry in all strains examined in this study, including the triple mutant
(Fig 4). These data indicate that an additional PEA transferase exists in H. ducreyi that has yet
to be identified. Studies are currently underway to find this transferase and to determine how
the LOS core KDO is modified with PEA.
When tested in the human model of H. ducreyi infection, 35000HPΔPEAT was fully viru-
lent. This result differs from previous in vivo studies in animal and human models of S. enterica
and N. gonorrhoeae infection. An eptA cptAmutant of S. enterica was modestly less fit than its
parent strain in mice [17]. In N. gonorrhoeae, LptA-mediated PEA modification of lipid A pro-
vided a significant fitness advantage in both female mice and human male volunteers [26].
In theH. ducreyi human challenge model, the initial disease (papules) at inoculated sites
may spontaneously resolve or progress to pustule formation; the overall parent pustule forma-
tion rate is 53.8% (n = 803 sites). In the present study, the pustule formation rate at parent-
inoculated sites was only 20.8%. With such a low parent pustule formation rate, it would be dif-
ficult to discern a difference in virulence between parent and mutant strains even if the mutant
was attenuated. It is also possible that the difference in susceptibility to defensins between the
parent and mutant strains observed in vitro may not be significant enough to correlate with at-
tenuation in vivo. Since 35000HPΔPEAT still has a PEA modification on its LOS, we cannot
say for certain that PEA transferases are not necessary for virulence inH. ducreyi; however,
these data show that lptA, ptdA, and ptdB are not required for H. ducreyi virulence in the
human model of infection.
The results of this trial raise the question of the importance of defensins in the host’s re-
sponse toH. ducreyi infection. Previous human trials examining the importance to pathogene-
sis of the Sap transporter, which confers resistance to LL-37 but not defensins, established a
direct correlation between LL-37 resistance in vitro and virulence in vivo: a sapAmutant with
partial loss of transporter-mediated LL-37 resistance was partially attenuated in vivo, and a
sapBCmutant, with no transporter activity, was fully attenuated for virulence [12,13]. Taken
together, these studies suggest that, during H. ducreyi infection, LL-37 plays a more significant
role than defensins in host defense. A greater impact of LL-37 than defensins on host defense
could also account for the greater role observed for N. gonorrhoeae LptA in human infection;
unlike its H. ducreyi homolog, N. gonorrhoeae LptA contributes to LL-37 resistance [22].
In summary, we identified three H. ducreyi genes that shared a high degree of homology to
known PEA transferases in other gram-negative bacteria. Deletion of all three genes resulted in
greater sensitivity to α- and β-defensins, a more negatively charged cell surface, and the loss of
PEA modification on lipid A. However, the triple mutant was fully virulent when tested in the
human model ofH. ducreyi infection. Our results suggest that defensins may play a lesser role
than LL-37 in host defense against H. ducreyi.
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S1 Fig. PEA transferases ofH. ducreyi confer resistance to α-defensins HNP-1 and HNP-2
and to β-defensin HBD-2. 35000HP/pLSSK, 35000HPΔPEAT/pLSSK, and 35000HPΔPEAT/
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pPEAT were tested for resistance to the α-defensins (A) HNP-1 and (B) HNP-2 and (C) the
β-defensin HBD-2. Asterisks indicate statistically significant differences from 35000HP
(P< 0.05). Complementation with pPEAT restored parental levels of susceptibility to defen-
sins. Data represent average ± standard error of three to four independent replicates, and
statistical significance was determined by Student’s t-test with Sidak adjustment for multiple
comparisons.
(TIF)
S2 Fig. Loss of putative PEA transferases ptdA and ptdB contributes to increased cell sur-
face negativity. The cell surface charges of 35000HP, 35000HPΔlptA (labeled as ΔlptA),
35000HPΔptdA (labeled as ΔptdA), 35000HPΔptdB (labeled as ΔptdB), 35000HPΔptdA ptdB
(labeled as ΔptdA ptdB), and 35000HPΔPEAT (labeled as ΔPEAT) were examined. The per-
centage of Alcian blue dye that bound to the bacteria, which correlates with a negatively
charged cell surface, was normalized to 35000HP for each sample. Data represent the
average ± standard error of five independent assays. An analysis was performed using a linear
regression of the number of genes against the raw values, including a random effect for date to
account for the correlation among values from the same experiment. A significant trend was
observed (P = 0.036).
(TIF)
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